These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 34604155)

  • 1. COVID-19 Outbreak and Financial Performance of Chinese Listed Firms: Evidence From Corporate Culture and Corporate Social Responsibility.
    Sun Y; Li Y
    Front Public Health; 2021; 9():710743. PubMed ID: 34604155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Financial performance of China's listed firms in presence of coronavirus: Evidence from corporate culture and corporate social responsibility.
    Zheng F; Zhao Z; Sun Y; Khan YA
    Curr Psychol; 2023; 42(11):8897-8918. PubMed ID: 34400856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Financial Redundancy on Corporate Social Responsibility Performance: Evidence From Chinese Listed Firms.
    He L; Gan S; Zhong T
    Front Psychol; 2022; 13():882731. PubMed ID: 35664182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the dynamics of capital structure, corporate governance, and corporate social responsibility in high- and low-leveraged US and Chinese firms.
    Mahmood AN; Arslan HM; Younas ZI; Komal B; Ali K; Mubeen M
    Environ Sci Pollut Res Int; 2023 Apr; 30(16):46204-46221. PubMed ID: 36710308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderating role of financial ratios in corporate social responsibility disclosure and firm value.
    Naseem MA; Lin J; Rehman RU; Ahmad MI; Ali R
    PLoS One; 2019; 14(4):e0215430. PubMed ID: 30998740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of expected financial performance on corporate environmental responsibility disclosure: evidence from China.
    Zeng Y; Gulzar MA; Wang Z; Zhao X
    Environ Sci Pollut Res Int; 2020 Oct; 27(30):37946-37962. PubMed ID: 32613511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of corporate environmental responsibility on financial performance-based on Chinese listed companies.
    Liu Y; Xi B; Wang G
    Environ Sci Pollut Res Int; 2021 Feb; 28(7):7840-7853. PubMed ID: 33040290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unveiling the Effectiveness of Agency Cost and Firms' Size as Moderators Between CSR Disclosure and Firms' Growth.
    Akram A; Tang Y; Tariq J
    Front Psychol; 2020; 11():1624. PubMed ID: 32903572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does digital finance promote corporate social responsibility of pollution-intensive industry? Evidence from Chinese listed companies.
    Xin D; Yi Y; Du J
    Environ Sci Pollut Res Int; 2022 Dec; 29(56):85143-85159. PubMed ID: 35790640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence in Asian Food Industry: Intellectual Capital, Corporate Financial Performance, and Corporate Social Responsibility.
    Tsai CH; Mutuc EB
    Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31968553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slack Resources, Corporate Performance, and COVID-19 Pandemic: Evidence from China.
    Jin L; Choi JH; Kim S; Cho K
    Int J Environ Res Public Health; 2022 Nov; 19(21):. PubMed ID: 36361231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How High-Polluting Firms Suffer from Being Distracted form Intended Purpose: A Corporate Social Responsibility Perspective.
    Zhao XZ; Chen J; Chen FW; Wang W; Xia S
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33317027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of COVID-19 on the Stock Price of Socially Responsible Enterprises: An Empirical Study in Taiwan Stock Market.
    Lee KJ; Lu SL
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33546396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corporate social responsibility in global health: an exploratory study of multinational pharmaceutical firms.
    Droppert H; Bennett S
    Global Health; 2015 Apr; 11():15. PubMed ID: 25886175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does CSR performance improve corporate immunity to the COVID-19 pandemic? Evidence from China's stock market.
    Tian J; Wang X; Wei Y
    Front Public Health; 2022; 10():956521. PubMed ID: 36052006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do financial performance and firm's value affect the quality of corporate social responsibility disclosure: Moderating role of chief executive officer's power in China.
    Na C; Tian G; Rauf F; Naveed K
    Front Psychol; 2022; 13():925323. PubMed ID: 36059787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Corporate Social Responsibility Heterogeneity Affect Corporate Financial Performance Through Technological Innovation? The Moderating Effects of Advertising Intensity.
    Niu M; Ma W
    Front Psychol; 2022; 13():837967. PubMed ID: 35898985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Pandemics on Corporate Innovation: Evidence From the Chinese Firms.
    Zhang C; Hu Y; Huang L; Huang Y
    Front Public Health; 2021; 9():780348. PubMed ID: 34805086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity of returnee executives' foreign experience and corporate social responsibility performance.
    Wu Y; Zhang W; Li H
    PLoS One; 2024; 19(4):e0300262. PubMed ID: 38557680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corporate social responsibility, internal control, and firm financial performance.
    Zhang L; Su W
    Front Psychol; 2022; 13():977996. PubMed ID: 36660285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.